• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FSMA Section 103(a) Study and Report to Congress

Description: FSMA Section 103(a) requires the Secretary, in consultation with USDA, to conduct a study of the food processing sector and information on foodborne illness and submit a report on the study to Congress on July 3, 2012. The study will provide information to be used in making decisions about the application of the preventive controls regulations to small businesses so that public health is still protected.

Briefing Status: DELAYED

Prior Briefing Status: DELAYED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Conduct study

11/30/2011

Completed 11/30/2011

B. Public comment period on study closed

1/13/2012

Delayed

C. Report draft completed

2/10/2012

Delayed

D. FSMA Teams review

2/24/2012

Delayed

E. Foods Program review

3/19/2012

Delayed

F. USDA & CDC review

4/13/2012

Delayed

G. FDA sign off

5/18/2012

Delayed

H. HHS sign off

6/15/2012

Delayed

I. Completion

6/29/2012

Delayed

J. Due to Congress

7/2/2012

Delayed

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.